Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
awardedOSAKIDETZA - Servicio Vasco de Salud - Organización Central · S5100023J
Value
€3.1m
Published
23 Oct 2026
Deadline
—
Type
award
33600000 · Medical equipment, pharmaceuticals & personal careES211
Description
Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Key facts
- Procedure
- open
- Contact
- contrata@osakidetza.eus
- Pre-award estimate
- €16m
- Regime
- publicSector
- Contract references
- 2026/01108252_00001
- Category
- supplies
Awarded suppliers
- Celltrion Farmaceutica SL · B70815097 · ES300, ES
Supplier location as published: Madrid, ES300, 28046, ES
Bid competition
Who else bid, as published on the notice. A bid is an offer, not money paid: nothing in this section is an award, and a firm named here was not necessarily paid anything.
Firms that bid
SANDOZ FARMACEUTICA S A · ADVANZ PHARMA SPAIN SL
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 736776-2026
- First seen
- 23 Oct 2026
- Last updated
- 23 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/5b623888-27c2-4ede-a6d1-713b25ee9896The source notice is authoritative — verify deadlines and documents there before bidding.